Quest Diagnostics Inc filed an 8-K on January 12, 2026, regarding its presentation at the 44th Annual J.P. Morgan Healthcare Conference where they will discuss the company's strategy and market trends. This filing is significant as it informs investors about upcoming discussions that may impact the company's performance and outlook.